Skip to main content

Table 2 The magnitude of GFP-specific CD8+ T cell responses as measured by IL-4 ELISPOT assay

From: An oral recombinant Salmonella enterica serovar Typhimurium mutant elicits systemic antigen-specific CD8+ T cell cytokine responses in mice

Stimulant

IL-4 SFUs/10e6 cells

p-value

 

AroC+GFP Group

AroC+pGEM Group

 

Media

16 ± 10

12 ± 2

0.55

GFP CD8 peptide

148 ± 56

12 ± 13

0.015

GFP protein

18 ± 13

29 ± 26

0.56

Salmonella LPS

55 ± 29

26 ± 9

0.17

Vaccine group

Media

GFP peptide

p-value

AroC+GFP

16 ± 10

148 ± 56

0.016

AroC+pGEM

12 ± 2

12 ± 13

0.97

  1. Groups of mice were vaccinated three times (Days 0, 28 and 56) with live recombinant Salmonella vaccine expressing GFP (AroC+GFP) or a negative Salmonella control vaccine not expressing any antigen (AroC+pGEM). On Day 84 (28 days after the last inoculation), splenocytes from the sacrificed mice were incubated with media only (negative assay control), or stimulated with GFP CD8+ T cell peptide (HYLSTQSAL), full-length GFP or Salmonella LPS in an IL-4 ELISPOT assay. The mean number of spots ± SD in triplicate wells was calculated and expressed as IL-4 SFUs/10e6 cells. Difference in response between or within vaccines was determined. Responses differ significantly if the p-values are less than 0.05 and do not differ significantly if the p-values are greater than 0.05.